The global sepsis diagnostics market was valued at USD 503.4 million in 2021 and it is anticipated to grow up to USD 1181.5 million by 2031, at a CAGR of 8.9% during the forecast period.

Sepsis is a potentially fatal illness that arises when the body’s immune system attacks its own tissues in reaction to an infection. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally. Septic shock can develop from sepsis. This is a sudden reduction in blood pressure that can cause serious organ damage and even death. Treatment with antibiotics and intravenous fluids as soon as possible enhances the chances of survival.

To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10358

Market Trends and Drivers

Rising incidence of hospital-acquired infections will augment the market growth during the forecast period. Hospital-acquired infections (HAIs), also known as nosocomial infections, are a major cause of morbidity and mortality worldwide. The most common hospital-acquired infections (HAIs) are urinary tract infections, pneumonia, and sepsis. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses.

Get A Customized Scope to Match Your, Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS10358

In the U.S., the incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide, the demand for sepsis diagnostic products is also expected to rise in the coming years.

Global Sepsis Diagnostics Market Segmentation

Product

• Instruments
• Blood Culture Media
• Assay Kits and Reagents

Technology

• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry

Pathogen

• Bacterial Sepsis
• Fungal Sepsis
• Others

Testing Type

• Laboratory Testing
• PoC Testing

End-use

• Hospitals and specialty clinics
• Pathology & Reference Laboratories
• Research Laboratories & Academic Institutes

For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/checkout/single_user/GIS10358

Major Players in the Global Sepsis Diagnostics Market

The key players in the market are bioMérieux (France), Becton, Dickinson and Company (US), Danaher Corporation (US), T2 Biosystems (US), Luminex (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), Bruker Corporation (US) and Abbott Laboratories (US), among others.

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC16192, Coastal Highway, Lewes DE 19958E-mail: [email protected]: +1–833–761–1700Website: https://www.globalinsightservices.com/